文献速递鼻科

表面活性剂鼻腔冲洗的安全性与耐受性

Safety and tolerability of surfactant nasal irrigation.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-05-30

一项在33名正常志愿者中开展的随机对照交叉研究显示,表面活性剂鼻腔冲洗可能导致嗅觉识别测试评分轻度下降(平均降低1.5分,p=0.012),18%(6/33)出现≥4分的临床意义下降,且中度或重度鼻塞报告率高于生理盐水冲洗(29% vs 6%,p=0.021)。结论认为表面活性剂鼻腔冲洗可能因鼻塞而存在耐受性问题,部分受试者可能出现可逆的嗅觉敏锐度下降。

要点

  • 表面活性剂冲洗后平均嗅觉识别测试评分降低1.5分,差异有统计学意义(p=0.012)。
  • 18%(6/33)受试者表面活性剂冲洗后嗅觉评分下降≥4分,生理盐水组仅3%(1/33)(p=0.046)。
  • 表面活性剂组29%(8/28)报告中度或重度鼻塞,生理盐水组仅6%(2/32)报告中度鼻塞(p=0.021)。

核心结论

  • 在正常志愿者中,表面活性剂鼻腔冲洗可能因鼻塞而存在耐受性问题。
  • 部分受试者可能出现嗅觉敏锐度下降,但似乎可逆。

研究设计与样本

  • 采用对照交叉研究设计,33名正常志愿者随机分配至表面活性剂溶液组或缓冲生理盐水组。
  • 受试者每日冲洗两次持续1周并记录日记,第2周停止治疗,第3周交换至另一治疗方案。
  • 每阶段后评估鼻内镜检查、40项嗅觉识别测试(SIT)及鼻塞程度。

主要发现

  • 表面活性剂使用导致平均SIT评分边际性降低1.5分,差异有统计学意义(p=0.012)。
  • SIT评分临床意义下降(≥4分)在表面活性剂组为18%(6/33),生理盐水组为3%(1/33)(p=0.046)。
  • 表面活性剂阶段29%(8/28)完成日记的受试者报告中度或重度鼻塞,生理盐水阶段仅6%(2/32)报告中度鼻塞(p=0.021)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abnormal mucus composition and bacterial biofilms are thought to contribute to the pathophysiology of rhinosinusitis. Addition of a mucoactive surfactant to saline irrigation solution has been hypothesized to address these factors. We evaluated the safety and tolerability of a reformulated surfactant in a sample of normal subjects. METHODS: A total of 33 volunteers were randomly assigned to receive either surfactant solution or buffered saline at baseline in a controlled crossover study design. Each subject underwent rhinoscopic exam and in-office smell testing via the 40-question smell identification test (SIT). Those with non-normosmic results or active rhinitis symptoms were excluded. Subjects were instructed to irrigate twice daily with the selected solution for 1 week while keeping a daily diary. For week 2, treatment was stopped. During week 3, each group switched to the other treatment. Exam, SIT, and degree of congestion were assessed after each phase. RESULTS: Use of surfactant led to a marginal reduction in mean SIT score of 1.5 points, which was statistically significant (p = 0.012). A clinically meaningful reduction in SIT score, defined as ≥4 points, was observed in 18% (6/33) of subjects after surfactant vs 3% (1/33) after saline (p = 0.046). During the surfactant phase, moderate or severe congestion was reported in 29% (8/28) of subjects completing the diary. In contrast, only 6% (2/32) of subjects reported moderate congestion after the saline phase (p = 0.021). CONCLUSION: In normal volunteers, surfactant nasal irrigation may be associated with tolerability issues due to congestion. A subset may experience reduction in olfactory acuity that appears reversible.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Turner JH, Wu J, Dorminy CA, et al. Safety and tolerability of surfactant nasal irrigation. Int Forum Allergy Rhinol. 2017. PMID: 28558139. doi:10.1002/alr.21959

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。